Bumetanide Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells
Condition:   Unresectable Hepatocellular Carcinoma Interventions:   Procedure: Hepatic artery embolization (HAE);   Drug: Bumetanide Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2017 Category: Research Source Type: clinical trials